Increased activity and expression of gelatinases in ischemic colitis

Digestive Diseases and Sciences

Volumn 51, Issue 12, 2006, Pages 2393-2399

  Medina, Carlos ^a   Santana, Alfredo ^a   Paz Cabrera, Maria Cristina ^a   Parra Blanco, Adolfo ^a   Nicolás, David ^a   Gimeno Garcia, Antonio Z ^a   Quintero, Enrique ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Gelatinases; Ischemic colitis; Matrix metalloproteinases; MMP 2; MMP 9

Indexed keywords

GELATINASE A; GELATINASE B;

AGED; ARTICLE; CASE CONTROL STUDY; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTESTINE MUCOSA; ISCHEMIC COLITIS; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLITIS, ISCHEMIC; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTESTINAL MUCOSA; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED;

EID: 33846994422     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-006-9255-5     Document Type: Article

References (34)

1. Bower TC (1993) Ischemic colitis. Surg Clin North Am 73:1037-1053
2. Gandhi SK, Hanson MM, Vernava AM, Kamiski DL, Longo WE (1996) Ischemic colitis. Dis Colon Rectum 39:88-100
3. Greenwald DA, Brandt LJ (1998) Colonic ischemia. J Clin Gastroenterol 27:122-128
4. Medina C, Vilaseca J, Videla S, Fabra R, Armengol-Miro JR, Malagelada JR (2004) Outcome of patients with ischemic colitis: Review of fifty-three cases. Dis Col Rectum 47:180-184
5. Barouk J, Gournay J, Bernard P, Masliah C, Le Neel JC, Galmiche JP (1999) Ischemic colitis in the elderly: predictive factors of gangrenous outcome. Gastroenterol Clin Biol 23:470-474
6. Woessner FJR (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154
7. Woessner FJR (1991) Literature on vertebrate matrix metalloproteinases and their tissue inhibitors. Matrix 1:425-501
8. Matrisian LM (1992) The matrix-degrading metalloproteinases. BioEssays 14:455-463
9. Nagase H, Barrett AJ, Woessner JR (1992) Nomenclature and glossary of the matirx metalloproteinases. Matrix 1:421-424
10. Woessner FJR (1994) The family of matrix metalloproteinases. Ann NY Acad Sci 732:11-21
11. Borkakoti N (1998) Matrix metalloproteinases: variations on a theme. Prog Biophys Mol Biol 70:73-94
12. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM (2000) Matrix metalloproteinases: Biologic activity and clinical implications. J Clin Oncol 18:1135-1149
13. Meikle MC, Atkinson SJ,Ward RV, Murphy G, Reynolds JJ (1989) Gingival fibroblasts degrade type I collagen films when stimulated with tumor necrosis factor and interleukin 1: evidence that breakdown is mediated by metalloproteinases. J Periodontal Res 24:207-213
14. Konttinen YT, Ceponis A, Takagi M, Ainola M, Sorsa T, Sutinen M, Salo T, Ma J, Santavirta S, Seiki M (1998) New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above. Matrix Biol 17:585-601
15. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS (1996) Reactive oxygen species produced by macrophage-derived foams cells regulate the activity of vascular matrix metalloproteinases in vitro: Implications for atherosclerotic plaque stability. J Clin Invest 98:2572-2579
16. Baugh M, Perry M, Hollander A, Davies DR, Cross SS, Lobo AJ, Taylor CJ, Evans GS (1999) Matrix metalloproteinases levels are elevated in inflammatory bowel disease. Gastroenterology 117:814-822
17. Von Lampe B, Barthel B, Coupland SE, Riecken EO, Rosewicz S (2000) Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 47:63-73
18. Heuschkel RB, MacDonald TT, Monteleone G, Bajaj-Elliott M, Smith JA, Pender SL (2000) Imbalance of stromelysin 1 and TIMP 1 in the mucosal lesions of children with inflammatory bowel disease. Gut 47:57-62
19. Stallmach A, Chan CC, Ecker KW, Feifel G, Herbst H, Schuppan D, Zeitz M (2000) Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis. Gut 47:415-422
20. Daum S, Bauer U, Foss HD, Wahnschaffe U, Schuppan D, Stein H, Riecken EO, Ullrich R (1999) Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut 44:17-25
21. Pender S, Tickle S,DochertyA,Howie D,Wathen NC,MacDonald TT (1997) A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 158:1582-1590
22. Pender SL, Fell JM, Chamow SM, Ashkenazi A, MacDonald TT (1998) A p55 TNF receptor immunoadhesin prevents T cellmediated intestinal injury by inhibiting matrix metalloproteinases production. J Immunol 160:4098-4103
23. Pender SL, Breese EJ, GuntherU,Howie D,Wathen NC, Schuppan D, MacDonald TT (1998) Supppression of T-cell mediated injury in human gut by interleukin 10: role of matrix metalloproteinases. Gastroenterology 115:573-583
24. Heussen C, Dowle EB (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecylsulfate and copolymerized substrate. Anal Biochem 102:196-202
25. SawickiG, Salas E, Murat J, Miszta-LaneH,RadomskiMW(1997) Release of gelatinase B during platelet activation mediates aggregation. Nature 386:616-619
26. Medina C, Videla S, Radomski A, Radomski MW, Antlín M, Guarner F, Vilaseca J, Salas A, Malagelada JR (2003) Increased activity and expression of matrix metalloproteinase-9 in a rat model of distal colitis. Am J Physiol Gastrointest Liver Physiol 284:116-122
27. Vaalamo M, Karjalainen-Lindsberg ML, Puolakkainen P, Kere J, Saarialho-Kere U (1998) Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol 152:1005-1014
28. Salmela MT, Pender SLF, Karjalainen-Lindsberg ML, Puolakkaimen P, MacDonald TT, Saarialha-Kere U (2004) Collagenase-1 (MMP-1), matrylisin-1 (MMP7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing. Scand J Gastroenterol 39:1095-1104
29. HovdenakN,Wang J, Sung CC, NellyT, FajardoLF, Haurer-Jensen M (2002) Clinical significance of increased gelatinolytic activity in the rectal mucosa during external beam radiation therapy of prostate cancer. Int J Radiat Oncol Biol Phys 53:919-927
30. Medina C, Videla S, Radomski A, Radomski MW, Antoín M, Guarner F, Vilaseca J, Salas A, Malagelada JR (2001) Therpaeutic effect of pheantroline in two rat models of inflammatory bowel disease. Scand J Gastroenterol 36:1314-1319
31. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA,Werb Z, Libby P, Lee RT (2000) Targeted deletion ofmatrixmetalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106:55-62
32. Huhtala P, Chow LT, Tryggvason K (1990) Structure of the human type IV collagenase gene. J Biol Chem 265:11077-11082
33. Huhtala P, Eddy RL, Fan YS, Byers MG, Shows TB, Tryggvason K (1990) Completion of the primary structure of the human type IV collagenase preproenzyme and assignment of the gene (CLG4) to the q21 region of chromosome 16. Genomics 6:554-559
34. Cowland JB, Borregaard N (1999) The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J Leukok Biol 66:989-995